Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.

Burrelli CC, Broadbent EK, Margulis A, Snyder GM, Gold HS, McCoy C, Mahoney MV, Hirsch EB.

Chemotherapy. 2018;63(6):345-351. doi: 10.1159/000499033. Epub 2019 Apr 9.

PMID:
30965335
2.

Facility type and surgical specialty are associated with suboptimal surgical antimicrobial prophylaxis practice patterns: a multi-center, retrospective cohort study.

Branch-Elliman W, Pizer SD, Dasinger EA, Gold HS, Abdulkerim H, Rosen AK, Charns MP, Hawn MT, Itani KMF, Mull HJ.

Antimicrob Resist Infect Control. 2019 Mar 6;8:49. doi: 10.1186/s13756-019-0503-9. eCollection 2019.

3.

Perioperative antimicrobial prophylaxis and prevention of hepatobiliary surgical site infections.

Stack CM, Gold HS, Wright SB, Baldini LM, Snyder GM.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1037-1041. doi: 10.1017/ice.2018.164. Epub 2018 Aug 1.

PMID:
30064539
4.

Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab.

Permpalung N, Mahoney MV, McCoy C, Atsawarungruangkit A, Gold HS, Levine JD, Wong MT, LaSalvia MT, Alonso CD.

Leuk Lymphoma. 2019 Jan;60(1):85-91. doi: 10.1080/10428194.2018.1468896. Epub 2018 Jun 27.

PMID:
29947555
5.

Nasal methicillin-resistant Staphylococcus aureus screening in patients with pneumonia: A powerful antimicrobial stewardship tool.

Smith EA, Gold HS, Mahoney MV, Hirsch EB, Giancola SE, Snyder GM, Marks G, Tran H, Hirai-Yang A, McCoy C.

Am J Infect Control. 2017 Nov 1;45(11):1295-1296. doi: 10.1016/j.ajic.2017.06.032. Epub 2017 Aug 24. No abstract available.

PMID:
28844378
6.

Randomized Comparison of 3 High-Level Disinfection and Sterilization Procedures for Duodenoscopes.

Snyder GM, Wright SB, Smithey A, Mizrahi M, Sheppard M, Hirsch EB, Chuttani R, Heroux R, Yassa DS, Olafsdottir LB, Davis RB, Anastasiou J, Bapat V, Bidari K, Pleskow DK, Leffler D, Lane B, Chen A, Gold HS, Bartley A, King AD, Sawhney MS.

Gastroenterology. 2017 Oct;153(4):1018-1025. doi: 10.1053/j.gastro.2017.06.052. Epub 2017 Jul 13.

PMID:
28711629
7.

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?

LaSalvia MT, Branch-Elliman W, Snyder GM, Mahoney MV, Alonso CD, Gold HS, Wright SB.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofw264. doi: 10.1093/ofid/ofw264. eCollection 2017 Winter.

8.
9.

Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination.

Kirby JE, Branch-Elliman W, LaSalvia MT, Longhi L, MacKechnie M, Urman G, Baldini LM, Muriel FR, Sullivan B, Yassa DS, Gold HS, Wagner TK, Diekema DJ, Wright SB.

J Clin Microbiol. 2017 Apr;55(4):1080-1089. doi: 10.1128/JCM.02336-16. Epub 2017 Jan 18.

10.

Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?

Branch-Elliman W, Stanislawski M, Strymish J, Barón AE, Gupta K, Varosy PD, Gold HS, Ho PM.

Infect Control Hosp Epidemiol. 2016 Sep;37(9):1005-11. doi: 10.1017/ice.2016.116. Epub 2016 Jun 20.

PMID:
27322021
11.

CLINICAL DECISIONS. Skin Abscess.

Wilbur MB, Daum RS, Gold HS.

N Engl J Med. 2016 Mar 3;374(9):882-4. doi: 10.1056/NEJMclde1600286. No abstract available.

PMID:
26962909
12.

More than Meets the Eye. A 23-Year-Old Woman with Rapidly Progressive Respiratory Failure, Mucositis, and Rash.

Parris RS, Cohen GM, Leahey PA, Gold HS, McSparron JI.

Ann Am Thorac Soc. 2015 Dec;12(12):1876-80. doi: 10.1513/AnnalsATS.201507-412CC. No abstract available.

PMID:
26653193
13.

Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Dien Bard J, Hindler JA, Gold HS, Limbago B.

Clin Infect Dis. 2014 May;58(9):1287-96. doi: 10.1093/cid/ciu043. Epub 2014 Jan 22.

14.

Health and economic burden of post-partum Staphylococcus aureus breast abscess.

Branch-Elliman W, Lee GM, Golen TH, Gold HS, Baldini LM, Wright SB.

PLoS One. 2013 Sep 5;8(9):e73155. doi: 10.1371/journal.pone.0073155. eCollection 2013.

15.

Risk factors for Staphylococcus aureus postpartum breast abscess.

Branch-Elliman W, Golen TH, Gold HS, Yassa DS, Baldini LM, Wright SB.

Clin Infect Dis. 2012 Jan 1;54(1):71-7. doi: 10.1093/cid/cir751. Epub 2011 Nov 3.

PMID:
22052894
16.

First report of prosthetic joint infection by Gemella sanguinis and associated "pseudosatelliting" phenomenon on culture.

Leung DT, Davis EM, Qian Q, Gold HS.

J Clin Microbiol. 2011 Sep;49(9):3395-7. doi: 10.1128/JCM.01050-11. Epub 2011 Jul 27.

17.

Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y.

Antimicrob Agents Chemother. 2010 May;54(5):2010-6. doi: 10.1128/AAC.01131-09. Epub 2010 Mar 8.

18.

Direct detection of methicillin resistance in Staphylococcus aureus in blood culture broth by use of a penicillin binding protein 2a latex agglutination test.

Qian Q, Venkataraman L, Kirby JE, Gold HS, Yamazumi T.

J Clin Microbiol. 2010 Apr;48(4):1420-1. doi: 10.1128/JCM.01517-09. Epub 2010 Feb 3.

19.

Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men.

Szumowski JD, Wener KM, Gold HS, Wong M, Venkataraman L, Runde CA, Cohen DE, Mayer KH, Wright SB.

Clin Infect Dis. 2009 Jul 1;49(1):118-21. doi: 10.1086/599608.

PMID:
19480576
20.

Antistaphylococcal agents.

Gold HS, Pillai SK.

Infect Dis Clin North Am. 2009 Mar;23(1):99-131. doi: 10.1016/j.idc.2008.10.008. Review.

PMID:
19135918
21.

Optimal use of Myco/F lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteria.

Kirby JE, Delaney M, Qian Q, Gold HS.

Arch Pathol Lab Med. 2009 Jan;133(1):93-6. doi: 10.1043/1543-2165-133.1.93.

PMID:
19123744
22.

Images in HIV/AIDS. Sweet syndrome and syphilis in an HIV-infected person.

Johnson LE, Armstrong AW, Dezube BJ, Tahan SR, Gold HS.

AIDS Read. 2008 Mar;18(3):134-5. No abstract available.

PMID:
18398981
23.

Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.

Tsakris A, Pillai SK, Gold HS, Thauvin-Eliopoulos C, Venkataraman L, Wennersten C, Moellering RC Jr, Eliopoulos GM.

J Antimicrob Chemother. 2007 Sep;60(3):649-51. Epub 2007 Jul 10.

PMID:
17623697
24.

Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.

Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC Jr, Eliopoulos GM.

Antimicrob Agents Chemother. 2007 Jun;51(6):2223-5. Epub 2007 Apr 2.

25.

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.

Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM.

J Antimicrob Chemother. 2006 Apr;57(4):699-704. Epub 2006 Feb 7.

PMID:
16464892
26.

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.

Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK.

J Clin Microbiol. 2006 Feb;44(2):595-7.

27.

Enterococcus: an emerging pathogen in hospitals.

Weber SG, Gold HS.

Semin Respir Crit Care Med. 2003 Feb;24(1):49-60.

PMID:
16088524
28.

Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Schlesinger J, Navon-Venezia S, Chmelnitsky I, Hammer-Münz O, Leavitt A, Gold HS, Schwaber MJ, Carmeli Y.

Antimicrob Agents Chemother. 2005 Mar;49(3):1150-6.

29.

Antimicrobial resistance to linezolid.

Meka VG, Gold HS.

Clin Infect Dis. 2004 Oct 1;39(7):1010-5. Epub 2004 Sep 10. Review.

PMID:
15472854
30.

Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.

Meka VG, Gold HS, Cooke A, Venkataraman L, Eliopoulos GM, Moellering RC Jr, Jenkins SG.

J Antimicrob Chemother. 2004 Oct;54(4):818-20. Epub 2004 Sep 3.

PMID:
15347637
31.

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami PC, Eliopoulos GM, Moellering RC Jr, Gold HS.

J Infect Dis. 2004 Jul 15;190(2):311-7. Epub 2004 Jun 9.

PMID:
15216466
33.

Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.

Kaye KS, Gold HS, Schwaber MJ, Venkataraman L, Qi Y, De Girolami PC, Samore MH, Anderson G, Rasheed JK, Tenover FC.

Antimicrob Agents Chemother. 2004 May;48(5):1520-5.

34.

Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens.

Schwaber MJ, Cosgrove SE, Gold HS, Kaye KS, Carmeli Y.

Emerg Infect Dis. 2004 Jan;10(1):94-9.

35.

Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.

Dibo I, Pillai SK, Gold HS, Baer MR, Wetzler M, Slack JL, Hazamy PA, Ball D, Hsiao CB, McCarthy PL Jr, Segal BH.

J Clin Microbiol. 2004 Apr;42(4):1843-5.

36.

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.

Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y.

Emerg Infect Dis. 2003 Nov;9(11):1415-22.

37.

Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia.

Schwaber MJ, Wright SB, Carmeli Y, Venkataraman L, DeGirolami PC, Gramatikova A, Perl TM, Sakoulas G, Gold HS.

Emerg Infect Dis. 2003 Jun;9(6):657-64. Erratum in: Emerg Infect Dis. 2004 Jan;10(1):160.

38.

Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.

Rahim S, Pillai SK, Gold HS, Venkataraman L, Inglima K, Press RA.

Clin Infect Dis. 2003 Jun 1;36(11):E146-8. Epub 2003 May 20.

PMID:
12766857
39.
40.

Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.

Sakoulas G, Gold HS, Venkataraman L, Moellering RC Jr, Ferraro MJ, Eliopoulos GM.

J Antimicrob Chemother. 2003 Apr;51(4):1039-41. No abstract available.

PMID:
12728937
41.

Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures.

Schwaber MJ, Krasner CN, Gold HS, Venkataraman L, Avigan DE, Karchmer AW, Uhl L.

J Clin Apher. 2003;18(1):37-9.

PMID:
12717792
42.

Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?

Sakoulas G, Eliopoulos GM, Moellering RC Jr, Novick RP, Venkataraman L, Wennersten C, DeGirolami PC, Schwaber MJ, Gold HS.

J Infect Dis. 2003 Mar 15;187(6):929-38. Epub 2003 Mar 6.

PMID:
12660939
43.

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.

Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC Jr, Ferraro MJ, Gold HS.

J Infect Dis. 2002 Dec 1;186(11):1603-7. Epub 2002 Nov 4.

PMID:
12447736
44.

Prevalence of the fsr locus in Enterococcus faecalis infections.

Pillai SK, Sakoulas G, Gold HS, Wennersten C, Eliopoulos GM, Moellering RC Jr, Inouye RT.

J Clin Microbiol. 2002 Jul;40(7):2651-2.

45.

Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.

Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, Novick RP, Gold HS.

Antimicrob Agents Chemother. 2002 May;46(5):1492-502.

46.

Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.

Sakoulas G, Gold HS, Venkataraman L, DeGirolami PC, Eliopoulos GM, Qian Q.

J Clin Microbiol. 2001 Nov;39(11):3946-51.

47.

Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance".

Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, Moellering RC Jr, Eliopoulos GM.

Clin Infect Dis. 2001 Nov 15;33(10):1654-60. Epub 2001 Oct 10.

PMID:
11595985
48.

Linezolid resistance in a clinical isolate of Staphylococcus aureus.

Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ.

Lancet. 2001 Jul 21;358(9277):207-8.

PMID:
11476839
49.

Vancomycin-resistant enterococci: mechanisms and clinical observations.

Gold HS.

Clin Infect Dis. 2001 Jul 15;33(2):210-9. Epub 2001 Jun 14.

PMID:
11418881
50.

Methicillin-susceptible Staphylococcus aureus: believe it, or not.

Sakoulas G, Degirolami PC, Gold HS.

Arch Intern Med. 2001 May 14;161(9):1237-8. No abstract available.

PMID:
11343454

Supplemental Content

Support Center